174 related articles for article (PubMed ID: 32933883)
1. The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19.
Kow CS; Hasan SS
Rev Esp Cardiol (Engl Ed); 2021 Jan; 74(1):114-115. PubMed ID: 32933883
[No Abstract] [Full Text] [Related]
2. ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study.
Ray JG; Vermeulen MJ; Schull MJ; Park AL
Clin Appl Thromb Hemost; 2021; 27():10760296211008986. PubMed ID: 33827287
[No Abstract] [Full Text] [Related]
3. COVID-19 and thrombosis: Prophylaxis and management.
Canoğlu K; Şaylan B; Çalışkan T
Tuberk Toraks; 2021 Jun; 69(2):269-278. PubMed ID: 34256519
[TBL] [Abstract][Full Text] [Related]
4. [COVID-19: Coagulopathy and thrombosis].
Tazi Mezalek Z
Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
[TBL] [Abstract][Full Text] [Related]
5. Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
Nauka PC; Baron SW; Assa A; Mohrmann L; Jindal S; Oran E; Glazman-Kuczaj G; Southern WN; Chekuri S
Thromb Res; 2021 Mar; 199():82-84. PubMed ID: 33476901
[No Abstract] [Full Text] [Related]
6. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
Kumar P; Mediwake R; Rhead C
Br J Hosp Med (Lond); 2020 May; 81(5):1-2. PubMed ID: 32468942
[No Abstract] [Full Text] [Related]
7. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
[TBL] [Abstract][Full Text] [Related]
8. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
Pizzi R; Gini G; Caiano L; Castelli B; Dotan N; Magni F; Virano A; Roveda A; Bertù L; Ageno W
Thromb Res; 2020 Dec; 196():209-212. PubMed ID: 32911392
[TBL] [Abstract][Full Text] [Related]
9. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.
Loo J; Spittle DA; Newnham M
Thorax; 2021 Apr; 76(4):412-420. PubMed ID: 33408195
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic therapeutic options for thromboprophylaxis in COVID-19.
Kow CS; Hasan SS
J Thromb Thrombolysis; 2021 Jan; 51(1):29-30. PubMed ID: 32596786
[No Abstract] [Full Text] [Related]
11. Venous thromboembolism in non-critically ill patients with COVID-19 infection.
Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O
Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275
[TBL] [Abstract][Full Text] [Related]
12. Post-hospitalization venous thromboembolism in COVID-19 patients: Evidence against routine post-hospitalization prophylactic anticoagulation.
Tan JY; Tan CW; Wong WH; Cheong MA; Lee LH; Kalimuddin S; Low JGH; Ng HJ
Int J Lab Hematol; 2022 Feb; 44(1):e4-e7. PubMed ID: 34146452
[No Abstract] [Full Text] [Related]
13. Ongoing trials on COVID-19 treatments: please, don't forget Venous Thromboembolism!
Zuin M; Zuliani G; Rigatelli G; Roncon L
J Thromb Thrombolysis; 2021 May; 51(4):1170-1171. PubMed ID: 33386562
[No Abstract] [Full Text] [Related]
14. A review of venous thromboembolism in COVID-19: A clinical perspective.
Ozsu S; Gunay E; Konstantinides SV
Clin Respir J; 2021 May; 15(5):506-512. PubMed ID: 33484090
[TBL] [Abstract][Full Text] [Related]
15. Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.
Di Micco P; Russo V; Lodigiani C
Medicina (Kaunas); 2020 Sep; 56(10):. PubMed ID: 32992511
[TBL] [Abstract][Full Text] [Related]
16. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
Vazquez FJ; Korin J; Baldessari EM; Capparelli FJ; Gutierrez P; Pale C; Bocanegra F; Grand B; Penchasky D; Gonzalez Alcántara MM; Prémoli MS; Tabares A; Wainsztein N; Odetto D; Vaccaro C; Martínez Aquino E; Cumpian O; Falabella V; Antuel García S; Saadi J; Siccardi M; Gándara E
Medicina (B Aires); 2020; 80 Suppl 3():65-66. PubMed ID: 32658849
[TBL] [Abstract][Full Text] [Related]
17. Highlights in COVID-19 from the 62nd American Society of Hematology Annual Meeting.
Kessler CM
Clin Adv Hematol Oncol; 2021 Mar; 19(3):140-143. PubMed ID: 33739961
[No Abstract] [Full Text] [Related]
18. A Review of Venous Thromboembolism Phenomena in COVID-19 Patients.
Kermani-Alghoraishi M; Ghahramani R
Curr Probl Cardiol; 2021 Mar; 46(3):100692. PubMed ID: 32994052
[TBL] [Abstract][Full Text] [Related]
19. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.
Hightower S; Ellis H; Collen J; Ellis J; Grasso I; Roswarski J; Cap AP; Chung K; Prescher L; Kavanaugh M; Brown T; Nau M; Clark P
Thromb Res; 2020 Nov; 195():69-71. PubMed ID: 32659463
[No Abstract] [Full Text] [Related]
20. Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy.
Balagholi S; Dabbaghi R; Eshghi P; Mousavi SA; Heshmati F; Mohammadi S
Transfus Apher Sci; 2020 Dec; 59(6):102993. PubMed ID: 33162341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
